Future mechanistic studies exploring the impact of DNA sensing by different cell types in a tumor via the cGAS-IFN-I pathway on DC and CD8+ T-cell functions, as well as on cancer cell immunogenicity, may lay the foundation for modulating this pathway to achieve effective cancer control. This evidence concerns the gene CGAS and neoplasm.